Chris Hunt is an experienced executive specializing in mergers and acquisitions, currently serving as the Head of M&A and a member of the Executive Leadership Team at Rentokil Initial since April 2012. Additionally, Chris has been a Board Member of the ICAEW Corporate Finance Faculty since August 2018. Prior experience includes a role as Director of Corporate M&A and Business Development at AstraZeneca, where responsibilities encompassed leading senior deals, overseeing non-core business, and managing finance strategy and execution for growth brands. Chris also held a Directorial position at KPMG Transaction Services, focusing on complex cross-border transactions. Chris holds an ACA from ICAEW and a BA Hons in Accounting with Computing from the University of Kent.
This person is not in any teams
This person is not in any offices